Menu

Filtros : "BIOQUÍMICA" "Financiamento NIH" Removido: "Elsevier" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico

    Bacterial selenocysteine synthase structure revealed by single-particle cryoEM (2024)

    Serrão, Vitor Hugo Balasco ; Minari, Karine ; Pereira, Humberto d'Muniz ; Thiemann, Otávio Henrique

    Source: Current Research in Structural Biology. Unidade: IFSC

    Subjects: BIOQUÍMICA, BACTÉRIAS (ESTUDO), METABOLISMO CELULAR

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SERRÃO, Vitor Hugo Balasco et al. Bacterial selenocysteine synthase structure revealed by single-particle cryoEM. Current Research in Structural Biology, v. 7, p. 100143-1-100143-8, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.crstbi.2024.100143. Acesso em: 13 nov. 2024.

    • APA

      Serrão, V. H. B., Minari, K., Pereira, H. d'M., & Thiemann, O. H. (2024). Bacterial selenocysteine synthase structure revealed by single-particle cryoEM. Current Research in Structural Biology, 7, 100143-1-100143-8. doi:10.1016/j.crstbi.2024.100143

    • NLM

      Serrão VHB, Minari K, Pereira H d'M, Thiemann OH. Bacterial selenocysteine synthase structure revealed by single-particle cryoEM [Internet]. Current Research in Structural Biology. 2024 ; 7 100143-1-100143-8.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.crstbi.2024.100143

    • Vancouver

      Serrão VHB, Minari K, Pereira H d'M, Thiemann OH. Bacterial selenocysteine synthase structure revealed by single-particle cryoEM [Internet]. Current Research in Structural Biology. 2024 ; 7 100143-1-100143-8.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1016/j.crstbi.2024.100143

  • Artigo de periodico

    Discovery and preclinical pharmacology of INE963, a potent and fast-acting blood-stage antimalarial with a high barrier to resistance and potential for single-dose cures in uncomplicated malaria (2022)

    Taft, Benjamin R.; Aguiar, Anna Caroline Campos

    Source: Journal of Medicinal Chemistry. Unidade: IFSC

    Subjects: ANTIMALÁRICOS, PLASMODIUM FALCIPARUM, PLANEJAMENTO DE FÁRMACOS, ANTIPARASITÁRIOS, MALÁRIA, BIOQUÍMICA, QUÍMICA MÉDICA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      TAFT, Benjamin R. e AGUIAR, Anna Caroline Campos. Discovery and preclinical pharmacology of INE963, a potent and fast-acting blood-stage antimalarial with a high barrier to resistance and potential for single-dose cures in uncomplicated malaria. Journal of Medicinal Chemistry, v. 65, n. 5, p. 3798-3813, 2022Tradução . . Disponível em: https://doi.org/10.1021/acs.jmedchem.1c01995. Acesso em: 13 nov. 2024.

    • APA

      Taft, B. R., & Aguiar, A. C. C. (2022). Discovery and preclinical pharmacology of INE963, a potent and fast-acting blood-stage antimalarial with a high barrier to resistance and potential for single-dose cures in uncomplicated malaria. Journal of Medicinal Chemistry, 65( 5), 3798-3813. doi:10.1021/acs.jmedchem.1c01995

    • NLM

      Taft BR, Aguiar ACC. Discovery and preclinical pharmacology of INE963, a potent and fast-acting blood-stage antimalarial with a high barrier to resistance and potential for single-dose cures in uncomplicated malaria [Internet]. Journal of Medicinal Chemistry. 2022 ; 65( 5): 3798-3813.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1021/acs.jmedchem.1c01995

    • Vancouver

      Taft BR, Aguiar ACC. Discovery and preclinical pharmacology of INE963, a potent and fast-acting blood-stage antimalarial with a high barrier to resistance and potential for single-dose cures in uncomplicated malaria [Internet]. Journal of Medicinal Chemistry. 2022 ; 65( 5): 3798-3813.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1021/acs.jmedchem.1c01995
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024